sotalol has been researched along with Eosinophilia in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szczeklik, A | 1 |
| Podolec, Z | 1 |
1 other study available for sotalol and Eosinophilia
| Article | Year |
|---|---|
Central regulation of blood eosinophilia by the beta-adrenergic system in rats.
Topics: Adrenalectomy; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Cell Count; Blo | 1976 |